Xingxu Yan

发表

A serum lipidomics study for the identification of specific biomarkers for endometrial polyps to distinguish them from endometrial cancer or hyperplasia

Guijiang Sun, Yubo Li, Huan Zhao, 2022, International journal of cancer.

Rapid screening of hepatotoxic components in Uncariae Ramulus Cum Uncis based on "component-target-pathway" network.

Shuo Wang, Xinyue Zhang, Yubo Li, 2022, Journal of pharmaceutical and biomedical analysis.

Serum Lipidomic Analysis Reveals Biomarkers and Metabolic Pathways of Thyroid Dysfunction

Hong-gang Zhao, Guijiang Sun, Yubo Li, 2023, ACS omega.

Application of lipidomics strategy to explore aging-related biomarkers and potential anti-aging mechanisms of ginseng

Xiaokai Li, Guijiang Sun, Yubo Li, 2021, Biogerontology.

Deep learning‐based multi‐omics study reveals the polymolecular phenotypic of diabetic kidney disease

Guijiang Sun, Yubo Li, Chuanxin Liu, 2023, Clinical and translational medicine.

Association Between Human Metabolomics and Rheumatoid Arthritis: A Systematic Review and Meta-analysis.

Hongqing Yin, Jingfang Li, Xingxu Yan, 2023, Archives of medical research.

Metabolomics biomarkers and related pathways in endometrial cancer: A systematic review and meta‐analysis

Xiaomeng Li, Xingxu Yan, Junjie He, 2024, Journal of Cellular and Molecular Medicine.

Clinical metabolomics characteristics of diabetic kidney disease: A meta‐analysis of 1875 cases with diabetic kidney disease and 4503 controls

Chenghao Bi, Xingxu Yan, Junjie He, 2024, Diabetes/metabolism research and reviews.

Unique metabolomics characteristics for distinguishing cirrhosis related to different liver diseases: A systematic review and meta-analysis.

Yanyan Xu, Chenghao Bi, Lexin Shu, 2024, Diabetes & metabolic syndrome.